成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Novus Biologicals, Inc.??? ?? ??? ?????.

?? ?:Novus Biologicals, Inc.
??:888 506 6887
???:novus@novusbio.com
??:United States
URL: www.novusbio.com
? ?? ?:175
1 2

?? ????

3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE
2-HYDROXYCINNAMALDEHYDE2-????????????3541-42-2C9H8O2
22(R)-HYDROXYCHOLESTEROL17954-98-2C27H46O2
2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE2-???-1-??-6-??????[4,5-B]???105650-23-5C13H12N4
(2R)-3-hydroxy-2-phosphonooxy-propanoic acidC3H7O7P
ANTI-PROTEIN KINASE C
ANTI-MCLOCK
ANTI-NMDAR2C
ANTI-CASPASE-9
ANTI-FEN-1
3T3 WHOLE CELL LYSATE
ANTI-HAP1
22(R)-HYDROXYCHOLESTEROL22348-64-7C27H46O2
ANTI-RPA14
ANTI-JAB1
ANTI-SOMATOSTATIN RECEPTOR (SSTR2A), HUMAN
ANTI-XPG
ANTI-XRCC3
ANTI-GABAA RECEPTOR
ANTI-PR (HUMAN) (PHOSPHORYLATED) (PSER294)
ANTI-NA+/K+ ATPASE BETA-1
ANTI-PARP
ANTI-RABBIT IGG HRP
ANTI-GABA-A RECEPTOR BETA 2 SUBUNIT
ANTI HUMAN RXR-GAMMA
ANTI-GABA-A RECEPTOR GAMMA 2 SUBUNIT
ANTI-DIMETHYL ARGININEC8H18N4O2
ANTI-MGLUR5
ANTI-RAD50
ANTI-ACETYL HISTONE
ANTI-GLYCINE RECEPTOR
ANTI-GABA A RECEPTOR (ALPHA6 SUBUNIT)
ANTI-NEUROFIBROMIN
ANTI-CYCLIN B1
ANTI-E2F-1
ANTI-NEUROFILAMENT-160 KD
ANTI-NMDAR2B
ANTI-SCAVENGER RECEPTOR CLASS B TYPE I
ANTI-CASPASE-8
ANTI-HISTONE H3
ANTI-DBH
ANTI-BLM
ANTI-GLUTAMATE RECEPTOR N-METHYL-D-ASPARTATE RECEPTOR NR1] [SPLICE VARIANT INSERT C2'
ANTI-MRAD50
ANTI-HUMAN N-MYC
ANTI-GFAP RAT MAB
ANTI-C-MYC EPITOPE TAG
ANTI-XERODERMA PIGMENTOSUM PROTEIN GROUP A
ANTI-NA(+)/CA(2+) EXCHANGER (NCX-1)
ANTI-CENP-F
ANTI-GAP-43
ANTI-RABBIT IGG, FITC CONJUGATED
ANTI-NEUROFILAMENT (PAN)
ANTI-ATM
ANTI-PERIPHERIN
ANTI-MITOSIN
ANTI-P53
ANTI-NEUROFILAMENT 68
ANTI-HUMAN IL-18 BPA
ANTI-NEUROKININ B RECEPTOR
ANTI-MMP-2
ANTI-GOAT IGG FLUORESCEIN
ANTI-CDK1
ANTI-B-GAL
ANTI-ORC1
ANTI-RETINOIC ACID RECEPTOR BETA
ANTI-MONOMETHYL ARGININEC7H16N4O2
11ALPHA-HYDROXYPROGESTERONE11-α-????????-4-?-3,20-??? ? ? ???80-75-1C21H30O3
ANTI-C-MYC
ANTI-CHK2
ANTI-SOMATOSTATIN RECEPTOR-I
ANTI-AIB1
ANTI-VANILLOID RECEPTOR
ANTI-HUMAN RAD17
ANTI-NMDAR1 C2
1 2
Copyright 2019 ? ChemicalBook. All rights reserved